Our data elucidate that BCR-ABL1, FLT3-ITD, RAF1, and BCL-XL suppress apoptosis induction in hydroxyurea-treated CML and AML cells. The gene discussed is RAF1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.